New Avandia suit filed in Texarkana
A Northeast Texas man has filed a personal injury suit against Smithkline Beecham Corp., doing business as GlaxoSmithKline, claiming Avandia cause a series of heart attacks.
After being diagnosed with type 2 diabetes in May of 2000, the man took Avandia for seven years as a way to improve control of his blood sugar levels. Now he believes the drug caused him to have heart attacks in 2003 and in 2006.
The suit claims that GlaxoSmithKline did know or should have known that Avandia can cause “heart injury, excessive fluid retention, fluid-overload disease, congestive heart failure, heart attack, liver damage, liver failure, and severe injury to the heart leading to cardiac arrest or death.”
As a result of several studies, in May 2007, the FDA issued a safety alert advising patients that there is a potentially significant risk of heart attacks and heart-related deaths. In November 2007, GlaxoSmithKline gave the drug a black box warning.
The suit alleges GlaxoSmithKline negligently allowed the public disclosure of positive information, but withheld or concealed negative information about Avandia’s safety and effectiveness.
If you have experienced adverse effects from taking Avandia or any other defective drug, you should seek the advice of a skilled, defective drugs attorney and determine if you are due any compensation for your injuries.